How one covid-19 vaccine race went from Oxford to an Italian lab overseeing trials

A lab outside Rome took “seed stock” produced at Oxford. Now U.S. and European officials are showing signs of support. That vaccine, like all the others designed to combat the pandemic, remains unproved. But it is further along in the trial process than the others, and it has turned into the West’s best — and perhaps only — chance to have a viable vaccine before the end of the year.

Publisher: Washington Post | Author: Chico Harlan

TAGS
vaccine
DATE PUBLISHED
2020-06-20 (Modified: 2021-05-18)

STAR RATING
[Total: 0   Average: 0/5]
VIEW RESOURCE
https://www.washingtonpost.com/world/europe/vaccine-coronavirus-oxford-italy-trials/2020/06/20/4b8f5e0a-af1c-11ea-98b5-279a6479a1e4_story.html

Leave a Reply